Hemex Health
Portland, United States· Est. 2013
The Gazelle diagnostic platform by Hemex Health detects and quantifies important blood-based conditions—from inherited disorders like sickle cell disease and beta thalassemia to iron-related and chronic conditions.
Private Company
Total funding raised: $5M
About
The Gazelle diagnostic platform by Hemex Health detects and quantifies important blood-based conditions—from inherited disorders like sickle cell disease and beta thalassemia to iron-related and chronic conditions.
Diagnostics
Funding History
3Total raised:$5M
Grant$500KJun 15, 2021
Series A$3MJun 15, 2020
Seed$1.5MJun 15, 2018